HIGHLIGHTS
- who: from the College, Hangzhou, Zhejiang, People`s Republic of China , Key Laboratory of Drug Safety Evaluation and Research of Zhejiang have published the article: Discovery of FOCAD: An Important Gene in Liver Cirrhosis, in the Journal: (JOURNAL)
- what: At present, drug development targeting this pathway is in full swing, and most of the research has focused on small_molecules and monoclonal_antibodies targeting CCR2. This study further showed the overproduction of CCL2 in FOCADdeficient patients and provided novel theoretical support for targeting the CCL2-CCR2 signaling axis as a potential target for liver disease patients. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.